GDUFA Research Outcomes
Nanotechnology Products
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to generic products that contain nanomaterials or nanotechnology (e.g., colloidal iron-carbohydrate and liposomal products).
-
Approaches Using Proactive Research in Support of Product-Specific Guidance (PSG) Development
Xu, Xiaoming
-
Demonstrating Complex Generic Product Equivalence: Benefits and Considerations When Using New Analytical Methods
Kozak, Darby
-
Navigating Formulation Assessments: General Q1/Q2 Inquiries to Supporting Complex Excipient Sameness
Kozak, Darby
-
Complex Generics Containing Nanomaterials: What�۪s Next in the Pipeline?
Jiang, Wenlei
-
Complex Generics Containing Nanomaterials: Developments in 2021 and 2022
Jiang, Wenlei
-
Complex Drug Products Containing Nanomaterials
Jiang, Wenlei
-
Liposome Guidance
Jiang, Wenlei
-
Regulating Generic Nanotechnology Drug Products: Guidance and Standards
Jiang, Wenlei
-
Regulatory Research in Nanomedicine Drug Products
Jiang, Wenlei
-
US FDA Perspectives for Bioequivalence (BE) Evaluation of Liposome Drug Products
Jiang, Wenlei